Alcoholism
European Patent Office Grants Hythiam Patent for Treatment of Alcohol Dependence
Published in Medical Patent Business Week, June 22nd, 2007
Hythiam, Inc. (NASDAQ:HYTM), a healthcare services management company that licenses the PROMETA(TM) treatment protocols designed to treat alcohol, methamphetamine and cocaine dependence, announced today that the European Patent Office has granted to Hythiam a patent for a use of a composition of matter for the treatment of alcohol dependence under European Patent Number 1374952. The patent will protect the intellectual property underlying the company's PROMETA Protocol for alcohol dependence. With this formal grant, the European patent can be validated in 19 designated European countries.
"We are excited by the momentum we have been enjoying in all areas of our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
More Articles from Medical Patent Business Week
- Barr Pharmaceuticals, Inc.
Barr Confirms Decision in Azithromycin Inventorship Suit - Biotechnology
BIO White Paper Dispels Over-Patenting Myth - Cancer
PhytoMedical To Develop New Class of Antitumour Agents Designed To Bind To DNA and Kill Cancer Cells - Diabetes
Recommended Changes to Enhance Minority Involvement in Clinical Research - Diagnostic Test
Corgenix AspirinWorks Test Kit Cleared by FDA - Drug Development
Barr Announces Tentative Approval for a Generic Version of Risperdal Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg - More from this issue of Medical Patent Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
